Literature DB >> 2445613

Treatment with an aldose reductase inhibitor can reduce the susceptibility of fast axonal transport following nerve compression in the streptozotocin-diabetic rat.

L B Dahlin1, D R Archer, W G McLean.   

Abstract

The effect of treatment with an aldose reductase inhibitor on the susceptibility of peripheral nerves to compression was studied in rats made diabetic by the injection of streptozotocin (50 mg.kg-1). The response to nerve compression was determined in untreated diabetic rats after 22 days of diabetes and compared with the response in two similar groups of diabetic rats which had been treated with the aldose reductase inhibitor 'Statil' (ICI 128436; 25 mg.kg-1.day-1 orally) either from the induction of diabetes or for 7 days prior to nerve compression. Two groups of non-diabetic rats were treated with 'Statil' for either 22 days or 7 days to act as controls. Inhibition of fast axonally transported proteins was induced by local compression of the sciatic nerves 4 h after application of 3H-leucine to the motor neurone cell bodies in the spinal cord. The inhibition of fast axonal transport was quantified by calculation of a transport block ratio. Compression at 30 mmHg for 3 h induced a significantly greater (p less than 0.05) inhibition of axonal transport at the site of compression in nerves of untreated diabetic rats (transport block ratio 0.96 +/- 0.24, n = 8) than in nerves of control rats treated with the aldose reductase inhibitor for either the shorter time of 7 days (0.71 +/- 0.17, n = 10) or the longer time of 22 days (0.69 +/- 0.08, n = 5).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2445613     DOI: 10.1007/bf00292544

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  34 in total

1.  Studies of sorbinil on axonal transport in streptozotocin-diabetic rats.

Authors:  G B Willars; D R Tomlinson; J P Robinson
Journal:  Metabolism       Date:  1986-04       Impact factor: 8.694

Review 2.  The pharmacology of aldose reductase inhibitors.

Authors:  P F Kador; W G Robison; J H Kinoshita
Journal:  Annu Rev Pharmacol Toxicol       Date:  1985       Impact factor: 13.820

Review 3.  Defects of axonal transport in diabetes mellitus--a possible contribution to the aetiology of diabetic neuropathy.

Authors:  D R Tomlinson; J H Mayer
Journal:  J Auton Pharmacol       Date:  1984-03

4.  Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.

Authors:  J H Mayer; D R Tomlinson
Journal:  Diabetologia       Date:  1983-11       Impact factor: 10.122

5.  Edema and increased endoneurial sodium in galactose neuropathy. Reversal with an aldose reductase inhibitor.

Authors:  A P Mizisin; H C Powell; R R Myers
Journal:  J Neurol Sci       Date:  1986-06       Impact factor: 3.181

6.  Increased endoneurial fluid pressure in galactose neuropathy.

Authors:  R R Myers; M L Costello; H C Powell
Journal:  Muscle Nerve       Date:  1979 Jul-Aug       Impact factor: 3.217

7.  Action of sorbinil in diabetic peripheral nerve. Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity.

Authors:  D A Greene; S A Lattimer
Journal:  Diabetes       Date:  1984-08       Impact factor: 9.461

8.  Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes.

Authors:  K H Gabbay; L O Merola; R A Field
Journal:  Science       Date:  1966-01-14       Impact factor: 47.728

9.  Axonal transport of protein in motor fibres of experimentally diabetic rats--fast anterograde transport.

Authors:  K F Meiri; W G McLean
Journal:  Brain Res       Date:  1982-04-22       Impact factor: 3.252

10.  The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats.

Authors:  D K Yue; M A Hanwell; P M Satchell; J R Turtle
Journal:  Diabetes       Date:  1982-09       Impact factor: 9.461

View more
  5 in total

1.  Pressure-induced inhibition of fast axonal transport of proteins in the rabbit vagus nerve in galactose neuropathy: prevention by an aldose reductase inhibitor.

Authors:  W G McLean
Journal:  Diabetologia       Date:  1988-07       Impact factor: 10.122

2.  Impaired induction of nerve ornithine decarboxylase activity in the streptozotocin-diabetic rat is prevented by the aldose reductase inhibitor ponalrestat.

Authors:  C Pekiner; W G McLean
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

3.  Phospho-Site-Specific Antibody Microarray to Study the State of Protein Phosphorylation in the Retina.

Authors:  Raju V S Rajala
Journal:  J Proteomics Bioinform       Date:  2008-08-13

Review 4.  Aldose reductase inhibitors and cataract.

Authors:  M J Crabbe
Journal:  Int Ophthalmol       Date:  1991-01       Impact factor: 2.031

5.  Retinal insulin receptor signaling in hyperosmotic stress.

Authors:  Raju V S Rajala; Ivana Ivanovic; Ashok Kumar Dilly
Journal:  Vitam Horm       Date:  2009       Impact factor: 3.421

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.